Thomas Gerlach

Thomas Gerlach has a diverse work experience spanning different roles and industries. Thomas is currently the Chief Strategy Officer (CSO) and co-founder of Pannex Therapeutics Inc. Thomas also serves as a Senior advisor at Mirscience Therapeutics.

Previously, Thomas worked as a Senior advisor at T.H.G. Advisors, where they provided innovation, strategy, and growth consulting in the pharma, health care, and biotech sectors.

Prior to that, they were the Director at FinHealth Gestão de Recursos, a venture capital company focused on healthcare. During their tenure, they invested in and provided guidance to several portfolio companies in the biotech, medical devices, diagnostics, and health IT sectors.

Thomas also held the role of Director of Business Development at Biozeus Biopharmaceuticals. Thomas played a key role in the company's growth and development.

Before their role at Biozeus, Thomas worked as the General Manager of Actelion Pharmaceuticals do Brasil, where they established the Brazilian affiliate and led market development efforts for rare diseases.

Earlier in their career, Thomas was a Project Leader and Director at Actelion Pharmaceuticals, Switzerland, where they managed the company's lead project and contributed to its growth and success.

Thomas also worked at Novartis, Switzerland as a Global Project Leader and Director, overseeing cross-functional teams and driving the development, life cycle management, and brand defense activities for new drugs.

Additionally, they served as an International Project Manager at Knoll AG, BASF Pharma Germany, and as a Visiting Scholar at Michigan State University.

Overall, Thomas Gerlach brings a wealth of experience in strategy, innovation, and leadership in the healthcare and life science sectors, working with both multinational companies and start-ups.

Thomas Gerlach obtained their PhD in Biology/Chemistry from Johannes Gutenberg-Universität in Mainz, Germany, between 1982 and 1988. Thomas then attended Michigan State University in East Lansing, MI, USA, from 1989 to 1992. The degree and field of study for this period are not provided.